RXRX Operating Cash Flow
Recursion Pharmaceuticals Inc Clas · Operating Cash Flow
RXRX Operating Cash Flow
Latest reported-$350.48Mperiod ending
RXRX TTM Operating Cash Flow (-$45.40M → -$350.48M)
TTM operating cash flow
High-resolution chart · PNG
RXRX operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -350,481,000 | |
| -320,952,000 | |
| -371,808,000 | |
| -441,165,000 | |
| -383,030,000 | |
| -388,831,000 | |
| -359,174,000 | |
| -317,821,000 | |
| -331,516,000 | |
| -316,764,000 | |
| -287,780,000 | |
| -258,451,000 | |
| -240,072,000 | |
| -234,228,000 | |
| -83,524,000 | |
| -99,934,000 | |
| -78,441,000 | |
| -50,471,000 | |
| -158,614,000 | |
| -88,883,000 | |
| -75,291,000 | |
| -58,337,000 | |
| -45,399,000 |